Efficacy and safety of azithromycin for uncomplicated typhoid fever: an open label non-comparative study

Anju Aggarwal1, Apurba Ghosh, Sunil Gomber

  • 1Department of Pediatrics, University College of Medical Sciences and Guru Tegh Bahadur Hospital, New Delhi, India.

Indian Pediatrics
|May 11, 2011
PubMed

Insights

Azithromycin effectively treated uncomplicated typhoid fever in children. The antibiotic demonstrated high clinical cure rates and was well-tolerated, showing it to be a safe and efficacious option.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Therapy

Background:

  • Typhoid fever remains a significant public health concern, particularly in resource-limited settings.
  • Effective and safe treatment options for pediatric typhoid fever are crucial for reducing morbidity and mortality.

Purpose of the Study:

  • To evaluate the efficacy and safety of azithromycin for treating uncomplicated typhoid fever in children aged 2-12 years.
  • To assess clinical and bacteriological cure rates and adverse events associated with azithromycin treatment.

Main Methods:

  • An open-labelled, non-comparative study involving 117 children with uncomplicated typhoid fever.
  • Azithromycin administered at 20mg/kg/day for 6 days.
  • Clinical assessment and BACTEC blood cultures were used to determine outcomes.

Main Results:

  • A clinical cure rate of 93.5% was observed in 102 children who completed the study.
  • Bacteriological cure was achieved in all 17 patients with positive blood cultures for Salmonella typhi.
  • No serious adverse events were reported, with good global well-being in 95% of cases.

Conclusions:

  • Azithromycin is a safe and efficacious antibiotic for managing uncomplicated typhoid fever in children.
  • The study supports the use of azithromycin as a viable treatment option for pediatric typhoid fever.
  • Further research could explore azithromycin's role in multidrug-resistant typhoid strains.

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...